| ACh | acetylcholine |
| AChE | acetylcholinesterase |
| AChR | acetylcholine receptor |
| ALG14 | asparagine-linked glycosylation 14 homolog |
| ALG2 | asparagine-linked glycosylation 2 homolog |
| AMC | arthrogryposis multiplex congenita |
| ASD | autism spectrum disorder |
| CaV1.1 | L-type calcium channel |
| CDG | congenital disorder of glycosylation |
| ChAT | choline acetyltransferase |
| CHD8 | chromatin helicase DNA binding protein 8 |
| ChEI | cholinesterase inhibitor |
| ChT | high affinity choline transporter |
| CK | creatine kinase |
| CMAP | compound muscle action potential |
| CMS | congenital myasthenic syndromes |
| CNS | central nervous system |
| ColQ | collagen Q |
| CTD | C-terminal domain of ColQ |
| Ctgf | connective tissue growth factor |
| D2L2AD | combined D-2- and L-2-hydroxyglutaric aciduria |
| DHMN7A | autosomal dominant distal hereditary motor neuropathy type VIIA |
| DHPR | dihydropyridine receptor |
| Dok-7 | docking protein 7 |
| DPAGT1 | dolichyl-phosphate N-acetylglucosamine phosphotransferase 1 |
| EBS | epidermolysis bullosa simplex |
| EPP | endplate potential |
| EVMPS | Escobar variant of multiple pterygium syndrome |
| FADS | fetal akinesia deformation sequence |
| FCCMS | fast-channel congenital myasthenic syndrome |
| Fgf18 | fibroblast growth factor 18 |
| GAP | Rho GTPase-activating protein |
| GFPT1 | glutamine--fructose-6-phosphate transaminase 1 |
| GMPPB | GDP-mannose pyrophosphorylase B |
| HCS | hypotonia-cystinuria syndrome |
| HSP | heparan sulfate proteoglycan |
| HSPBD | HSP-binding domain |
| IBM | inclusion body myositis |
| IDDAM | intellectual developmental disorder with autism and macrocephaly |
| LAP1 | lamin-associated protein 1 |
| LEMS | Lambert-Eaton myasthenic syndrome |
| LGMD17 | autosomal recessive limb-girdle muscular dystrophy 17 |
| LMPS | lethal form of multiple pterygium syndrome |
| LRP4 | low density lipoprotein receptor-related protein 4 |
| MDDG | muscular dystrophy-dystroglycanopathy |
| MG | myasthenia gravis |
| MuSK | muscle-specific receptor tyrosine kinase |
| Myo9a | myosin 9A |
| NaV1.4 | Skeletal muscle voltage-gated sodium channel |
| NCAM | neuronal cell adhesion molecule |
| NIPPV | non-invasive positive pressure ventilation |
| NMJ | neuromuscular junction |
| PRAD | proline-rich attachment domain |
| PREPL | propyl endopeptidase like |
| PURA | purine-rich element-binding protein A |
| R-CMAP | repetitive compound muscle action potential |
| RNS | repetitive nerve stimulation |
| Rspo2 | R-spondin 2 |
| RyR | ryanodine receptor |
| SCCMS | slow-schannel congenital myasthenic syndrome |
| SFEMG | single-fiber electromyography |
| SIDS | sudden infantile death syndrome |
| SNARE | soluble NSF attachment protein receptor |
| SNV | single nucleotide variant |
| SOST2 | sclerosteosis type 2 |
| SR | sarcoplasmic reticulum |
| SSRI | selective serotonin reuptake inhibitor |
| SV2A | synaptic vesicle glycoprotein 2A |
| UDP-GlcNAc | uridine diphosphate N-acetylglucosamine |
| vAChT | vesicular acetylcholine transporter |
| VAMP1 | vesicle-associated membrane protein 1 |
| VGCC | voltage-gated calcium channel |